京东健康(06618)与凯基信诚达成深度合作全网首发新药新舒沐®和凯沐沐®

智通财经网01-08

智通财经APP获悉，近日，京东健康(06618)与本土创新药企业凯基信诚生物医药科技有限公司(以下简称：凯基信诚)达成深度合作。双方将整合京东健康在医疗服务与即时零售领域的优势资源，助力中国慢性乙肝患者实现临床治愈的目标。与此同时，凯基信诚旗下全球首个采用HepDirectTM肝靶向技术研发的治疗慢乙肝的1类创新药甲磺酸普雷福韦片(商品名：新舒沐®)和补充肝脏营养的锌硒多种维生素软胶囊(商品名：...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2601564703?lang=zh_CN&edition=full","thumbnail":"https://img.zhitongcaijing.com/image/20260108/20260108154010_62150.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","is_english":false,"pubTime":"2026-01-08 15:39","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2601564703","market":"sh","top_or_hot":-1,"title":"京东健康(06618)与凯基信诚达成深度合作 全网首发新药新舒沐®和凯沐沐®","media":"智通财经网","content":"<div>\n<p>智通财经APP获悉，近日，京东健康(06618)与本土创新药企业凯基信诚生物医药科技有限公司(以下简称：凯基信诚)达成深度合作。双方将整合京东健康在医疗服务与即时零售领域的优势资源，助力中国慢性乙肝患者实现临床治愈的目标。与此同时，凯基信诚旗下全球首个采用HepDirectTM肝靶向技术研发的治疗慢乙肝的1类创新药甲磺酸普雷福韦片(商品名：新舒沐®)和补充肝脏营养的锌硒多种维生素软胶囊(商品名：...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1390321.html\">网页链接</a>\n\n</div>\n","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>京东健康(06618)与凯基信诚达成深度合作 全网首发新药新舒沐®和凯沐沐®</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n京东健康(06618)与凯基信诚达成深度合作 全网首发新药新舒沐®和凯沐沐®\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-08 15:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1390321.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，近日，京东健康(06618)与本土创新药企业凯基信诚生物医药科技有限公司(以下简称：凯基信诚)达成深度合作。双方将整合京东健康在医疗服务与即时零售领域的优势资源，助力中国慢性乙肝患者实现临床治愈的目标。与此同时，凯基信诚旗下全球首个采用HepDirectTM肝靶向技术研发的治疗慢乙肝的1类创新药甲磺酸普雷福韦片(商品名：新舒沐®)和补充肝脏营养的锌硒多种维生素软胶囊(商品名：...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1390321.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1142","symbol_name":"互联网与直销零售","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1390321.html","article_id":"2601564703","we_media_id":null,"thumbnails":["https://img.zhitongcaijing.com/image/20260108/20260108154010_62150.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601564703","pubTimestamp":1767857972,"columns":[],"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"近日，京东健康(06618)与本土创新药企业凯基信诚生物医药科技有限公司(以下简称：凯基信诚)达成深度合作。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"86618":"京东健康-R","BK1142":"互联网与直销零售","06618":"京东健康","BK1591":"就地过年概念","BK1615":"港股-互联网","BK1515":"抗疫概念","BK1571":"互联网医疗","SGXZ86797644.SGD":"MAYBANK ASIAN GROWTH AND INCOME-I \"A\" (SGDHDG) INC","BK1247":"药品零售","LU0051755006.USD":"摩根大通中国A (dist)","BK1583":"高瓴概念","BK1589":"北水核心资产","SGXZ62798434.SGD":"MAYBANK ASIAN GROWTH AND INCOME-I \"A\" (SGDHDG) ACC","LU0456827905.SGD":"JPMorgan Funds - China A (acc) SGD"},"translate_title":"JD Health (06618) and KGI Xincheng reached an in-depth cooperation to launch the new drug Xinshumu on the entire network ® He Kai Mumu ®","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"86618":0.6,"06618":1.5},"content_text":"智通财经APP获悉，近日，京东健康(06618)与本土创新药企业凯基信诚生物医药科技有限公司(以下简称：凯基信诚)达成深度合作。双方将整合京东健康在医疗服务与即时零售领域的优势资源，助力中国慢性乙肝患者实现临床治愈的目标。与此同时，凯基信诚旗下全球首个采用HepDirectTM肝靶向技术研发的治疗慢乙肝的1类创新药甲磺酸普雷福韦片(商品名：新舒沐®)和补充肝脏营养的锌硒多种维生素软胶囊(商品名：凯沐沐®)在京东健康全网独家首发，为慢性乙肝患者及需要肝健康保护的人群带来更精准，便捷的全链路服务。此次全网首发的甲磺酸普雷福韦片(商品名：新舒沐®)适用于治疗成人慢性乙型肝炎。该药曾连续获得国家“十二五”“十三五”重大新药创制科技专项支持。它可将活性药物靶向递送至肝脏，实现增效减毒。Ⅲ期临床研究结果显示：试验组抑制病毒更加强效持久;对于HBsAg的降低幅度、降至<1000  IU/mL的患者比例均显著优于对照组(P<0.05)，也优于同类药物。值得一提的是，相较于同类药物，该药不受食物影响，服用更加方便。锌硒多种维生素软胶囊(商品名：凯沐沐®)专为肝脏营养及适用于需要补充锌、硒及多种维生素的人群。该药富含维生素A、维生素B1、维生素B2、维生素B6、维生素B12、烟酰胺、维生素C、维生素K、维生素E等9种维生素，以及锌、硒2种矿物质，经过临床专家论证科学配比，同时利用大豆磷脂胶囊锁鲜，更易吸收。每天两粒便携易服，持续守护肝健康。京东健康将充分发挥自身“线上问诊+医药零售+即时配送”的生态优势，通过“专业供给+专科医生在线指导+极速送达服务”三位一体的服务闭环，让这两款新药快速普及，为相关患者提供更优选项。即日起，患者即可通过京东APP或全国各地京东大药房凭有效处方购买这两款新药。后续，京东健康将联合凯基信诚，充分整合双方的核心优势，持续深化战略协同，共同优化患者全流程服务体验，提升医药供应链的整体效率与质量，推动合作项目扎实落地，实现共赢发展。京东健康相关负责人表示，京东健康一直致力于为消费者提供优质的医药健康产品和服务。此次与凯基信诚的合作，双方将充分发挥自身能力优势，助力甲磺酸普雷福韦片和锌硒多种维生素软胶囊等创新药物快速触达更广泛的患者群体。近年来，京东健康“新特药首发第一站”的价值效应持续放大。一大批前沿创新药品，通过包括京东大药房DTP药房在内的线上线下一体化渠道，触达广大患者，帮助他们获得更加精准高效、体验更好的治疗方案。未来，京东健康将联合全球药企合作伙伴，共同提升新特药的可及性，为“健康中国2030”战略目标贡献更多力量。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2601564703","isCrawlerRequest":true}

京东健康(06618)与凯基信诚达成深度合作 全网首发新药新舒沐®和凯沐沐®

精彩评论

京东健康(06618)与凯基信诚达成深度合作全网首发新药新舒沐®和凯沐沐®